A new experimental drug, ANB033, shows early promise in protecting people with celiac disease from gluten-induced intestinal damage and symptoms.
Indian pharma innovation is gaining momentum as companies and policymakers focus on R&D investment, clinical trials, and new drug development.
Pharma’s Day of Deals spotlights an AI obesity push, a digital pathology buy, and fresh funds for Indian biotech innovation.
Telemedicine is transforming senior chronic care through remote monitoring, virtual consultations, and accessible digital tools that help older adults manage chronic conditions safely at home.
Arthritis care starts with informed daily choices. This World Arthritis Day, experts highlight essential do’s and don’ts to protect joint health, manage symptoms, and maintain mobility.
AI drug discovery funding in India gains momentum as TDB backs Peptris with Rs 86 crore to advance four drug candidates through preclinical development.
India’s pharma regulatory landscape is expanding beyond manufacturing compliance, with new developments targeting medicine pricing, sterile-drug quality, medical marketing, and obesity treatment.
Drug development faces mounting safety concerns, clinical setbacks, and pressure to modernize standards. Three industry moves reveal how pharma balances risk management with faster, more efficient development.
In an exclusive interaction with Thiruamuthan, Assistant Editor at India Pharma Outlook, Pushkar Kulkarni, General Manager, Johnson & Johnson Innovative Medicine, India & South Asia, discusses how technology, AI, genomics and precision medicine are s
HPV shot before pregnancy may cut preterm birth risk, adding another potential benefit to established cancer prevention.
.jpg)
, CDSCO.jpg)
